ECCO-ESPGHAN guideline update for paediatric Crohn's disease: high-risk patients should start anti-TNF therapy first line with proactive and reactive drug monitoring; exclusive enteral nutrition or CDED with partial enteral nutrition is preferred for low-risk luminal disease.
Guideline
Shouval et al. Management of pediatric Crohn's disease: an ECCO-ESPGHAN guideline update